(Q37967642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

A statistician's perspective on biomarkers in drug development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Athula Herath

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Martin Jenkins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Aiden Flynn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Trevor Smart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chris Harbron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tony Sabin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jayantha Ratnayake

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Philip Jarvis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

James Matcham

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PSI Biomarker Special Interest Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

Pharmaceutical Statistics

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

494-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162336%20AND%20SRC:MED&resulttype=core&format=json

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

18 January 2020

cites work

1 reference

An approach to the validation of markers for use in AIDS clinical trials

21 January 2018

1 reference

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

Prognostic versus predictive value of biomarkers in oncology.

21 January 2018

1 reference

A re-evaluation of random-effects meta-analysis.

21 January 2018

1 reference

Almost all articles on cancer prognostic markers report statistically significant results

21 January 2018

1 reference

Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses

21 January 2018

1 reference

Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans

21 January 2018

1 reference

Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study

21 January 2018

1 reference

The use of baseline covariates in crossover studies

21 January 2018

1 reference

Fit-for-purpose method development and validation for successful biomarker measurement.

21 January 2018

1 reference

2009 Biospecimen research network symposium: advancing cancer research through biospecimen science.

21 January 2018

1 reference

Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.

21 January 2018

1 reference

Randomized clinical trials with biomarkers: design issues

21 January 2018

1 reference

Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears

21 January 2018

1 reference

Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure

21 January 2018

1 reference

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

21 January 2018

1 reference

Biomarker discovery for colon cancer using a 761 gene RT-PCR assay.

21 January 2018

1 reference

Human biospecimen research: experimental protocol and quality control tools

21 January 2018

1 reference

Biomarkers in drug development: friend or foe? A personal reflection gained working within oncology.

21 January 2018

1 reference

Bias and confounding in molecular epidemiological studies: special considerations.

21 January 2018

1 reference

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen

21 January 2018

1 reference

Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation

21 January 2018

1 reference

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance

21 January 2018

1 reference

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Biomarkers in oncology drug development

21 January 2018

1 reference

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

I/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray data

21 January 2018

1 reference

Multidimensional local false discovery rate for microarray studies

21 January 2018

1 reference

PLS-regression: a basic tool of chemometrics

21 January 2018

1 reference

k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction

21 January 2018

1 reference

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

21 January 2018

Support-vector networks

1 reference

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

21 January 2018

1 reference

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

21 January 2018

1 reference

Clinical Experience with Trastuzumab (Herceptin)

21 January 2018

1 reference

Role of warfarin pharmacogenetic testing in clinical practice

21 January 2018

1 reference

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

21 January 2018

1 reference

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

Integrating biomarkers in clinical trials

21 January 2018

1 reference

Randomized phase III clinical trial designs for targeted agents

21 January 2018

1 reference

Statistical issues in translational cancer research

21 January 2018

1 reference

Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect.

21 January 2018

1 reference

Drug-induced acute kidney injury

21 January 2018

1 reference

Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury

21 January 2018

1 reference

A framework to assess the translation of safety pharmacology data to humans.

21 January 2018

1 reference

Diagnostic tests 2: Predictive values

21 January 2018

1 reference

Bayesian estimation of the receiver operating characteristic curve for a diagnostic test with a limit of detection in the absence of a gold standard

21 January 2018

1 reference

Interval estimation for the difference in paired areas under the ROC curves in the absence of a gold standard test

21 January 2018

1 reference

Next-generation biomarkers for detecting kidney toxicity

21 January 2018

1 reference

Creatinine as the gold standard for kidney injury biomarker studies?

21 January 2018

1 reference

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

A perfect correlate does not a surrogate make

21 January 2018

1 reference

Statistical evaluation of biomarkers as surrogate endpoints: a literature review

21 January 2018

1 reference

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

Meta-analysis for the evaluation of potential surrogate markers.

21 January 2018

1 reference

Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

21 January 2018

1 reference

Predicting treatment effects using biomarker data in a meta‐analysis of clinical trials

21 January 2018

1 reference

Criteria for the validation of surrogate endpoints in randomized experiments.

21 January 2018

1 reference

The validation of surrogate endpoints in meta-analyses of randomized experiments

21 January 2018

1 reference

Biomarkers and surrogate end points--the challenge of statistical validation

21 January 2018

1 reference

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset

21 January 2018

1 reference

A direct approach to false discovery rates

21 January 2018

1 reference

Surrogate Endpoints And FDA’s Accelerated Approval Process

21 January 2018

1 reference

Assurance in clinical trial design

21 January 2018

1 reference

Towards consensus practices to qualify safety biomarkers for use in early drug development

21 January 2018

1 reference